Posted inBiotechnology
ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2, setting stage for pivotal program
When looking out across the competitive GLP-1 landscape, AstraZeneca might not be the first Big Pharma name that comes to…
Posted inMedical Technology
Galmed acquires Colospan in $4.5M deal as it eyes $6B GI dx market
Galmed Pharmaceuticals acquired Colospan in a $4.5 million deal as the Israel-based biotech looks to create a gastrointestinal platform targeting…
Posted inMedical Technology
Roche sticks with €600M diagnostics investment in Germany but warns of future risk
As news hit last week that Eli Lilly and Boehringer Ingelheim are cutting investments in Germany, Roche said it will…
Posted inBiotechnology
Fueled by M&A and partnerships, biotech is poised for continued growth: EY
Ernst & Young is projecting biotech revenues will grow by at least 12% in 2026, recording growth for the third…
Posted inBiotechnology
Muscle Quality Differences in Older Fallers Revealed
In a groundbreaking study published in BMC Geriatrics, a team of researchers led by Kantha, Lapanan, Phongjit, and colleagues has…
Posted inBiotechnology
Photoimmunotherapy Targets CD98 in Solid Tumors
In a groundbreaking advance in cancer treatment, researchers have unveiled the promising therapeutic potential of photoimmunotherapy targeting solid tumors expressing…
Posted inBiotechnology
Assessing Fragility Fracture Risks to Prevent Falls
As the global population ages, one of the most pressing public health challenges is addressing the health and wellbeing of…
Posted inBiotechnology
New Study Connects Even Minimal Alcohol Intake to Cancer, Heart Disease, and Early Mortality
A groundbreaking study published in the Journal of Studies on Alcohol and Drugs has delivered a decisive message challenging widespread…
Posted inBiotechnology
New Study Reveals Even Low Alcohol Intake Increases Risk of Cancer, Heart Disease, and Early Death—Findings Absent from Current Dietary Guidelines
A groundbreaking study recently published in the Journal of Studies on Alcohol and Drugs has delivered a sobering reassessment of…
Posted inMedical Technology
CeQur nabs $100M series E to fuel insulin patch commercialization
Swiss medtech CeQur has raised $100 million in a new series E funding round for what it called its “most…